01:15 , Nov 3, 2015 |  BC Extra  |  Company News

Management tracks

Biosimilar company Therapeutic Proteins International LLC (Chicago, Ill.) named Peter Moesta CEO. Moesta was SVP of biologics development and operations at Bristol-Myers Squibb Co. (NYSE:BMY). Diagnostic play Exosome Diagnostics Inc. (Cambridge, Mass.) named John Boyce...
07:00 , Apr 21, 2014 |  BC Week In Review  |  Company News

Bio-Rad Laboratories, GnuBIO deal

Tool supplier Bio-Rad acquired GnuBIO for an undisclosed sum. GnuBIO's droplet-based DNA sequencing technology uses microfluidic and emulsion technology to perform multiplexed reactions in droplets. In 2012, GnuBIO received a three-year, $4.5 million grant from...
07:00 , Apr 15, 2013 |  BC Week In Review  |  Financial News

GnuBIO completes venture financing

GnuBIO Inc. , Cambridge, Mass.   Business: Diagnostic   Date completed: 10/4/12   Type: Venture financing   Raised: $10 million   Investors: Private investors; existing investors  ...
07:00 , Oct 22, 2012 |  BC Week In Review  |  Company News

GnuBIO management update

GnuBIO Inc. , Cambridge, Mass.   Business: Diagnostic   Promoted: Susie Harborth to CFO from SVP of business operations  ...
07:00 , Sep 24, 2012 |  BC Week In Review  |  Company News

GnuBIO, National Human Genome Research Institute genomics news

GnuBIO received a three-year, $4.5 million Phase II Small Business Innovation Research (SBIR) grant from the institute's Advanced DNA Sequencing Technology Program. The company will use the funds to further develop its Microfluidic DNA Sequencing...
08:00 , Jan 16, 2012 |  BC Week In Review  |  Company News

GnuBIO, Montreal Heart Institute deal

GnuBIO and the institute partnered to develop and validate a set of sudden cardiac death (SCD) genes using GnuBIO's DNA sequencing system. The results will be used to develop a sequencing test to assess the...
01:14 , Sep 16, 2010 |  BC Extra  |  Politics & Policy

NHGRI awards genome sequencing grants

The National Human Genome Research Institute awarded a total of $18.1 million in grants to 10 teams to fund the development of third-generation DNA sequencing technologies, with a goal of enabling a human genome to...